-
Corona Remedies
2,224.35 2,261.40(%) -
Cams Services
681.75 611.70(%) -
ESDS Software
1,560.35 1,418.50(%) -
Power Grid Corpn
272.00 324.80(%) -
Avenue Super.
3,664.10 3,528.65(%) -
Molbio Diagnosti
1,509.70 1,291.00(%) -
Ather Energy
1,661.80 1,741.90(%) -
Reliance Industries
1,267.00 1,250.55(%) -
Hero Motocorp
5,280.00 6,390.00(%) -
HDFC Bank
694.50 1,020.35(%) -
Tata Motors PVeh
300.10 294.15(%) -
United Breweries
1,254.00 1,245.10(%) -
ASM Technologies
7,248.00 6,990.00(%) -
Swan Corp
315.60 506.20(%) -
Bharti Airtel
1,848.80 2,174.70(%) -
Swiggy
278.75 235.85(%) -
KEI Industries
4,580.45 3,730.00(%) -
Netweb Technol.
5,047.00 5,810.00(%) -
IFCI
84.61 46.20(%) -
Axis Bank
1,260.00 1,418.30(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Camlin Fine Sciences Ltd Chemicals
- Indian Private
- BSE Code : 27793.0
- ISIN : INE052I01032
-
Today’s Low
102.84 -
Today’s High
105.30
-
Open
104.15 -
Perv Close
104.15 -
52W Low
96.21 -
52W High
235.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
1,993.96
-
Div & Yield %
0.00
-
Book Value(₹)
48.18
-
Debt-Equity Ratio
-0.34
-
AGM Date
09-Sep-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.94
-
Mar.Cap (₹Cr.)
1,993.96
-
RONW (%)
-13.30
-
ROCE (%)
8.38
Score Board
-
Equity (₹ in Cr.)
19.21
-
BV (₹)
48.20
-
Sales( ₹ in Cr.)
837.92
-
NP (in Cr.)
-15.42
-
NP Var(%)
-184.0
-
Div%
0.0
-
CPS (₹)
2.00
-
EPS (₹)
-0.80
-
Traded Value (₹ in Lakhs)
1,996.84
-
52 Week High
235.00
-
52 Week Low
96.21
-
Price BSE
104.0
-
Price NSE
104.00
-
Market Capital( in Cr.)
1,996.84
-
P/C Ratio
52.20
-
P/E Ratio
-129.50
-
Price Vs.BV
-0.80
-
09-Sep-2026( 03:52)
Corporate News - Camli... - <p>Camlin Fine Sciences Limite...
-
11-Aug-2026( 06:50)
Results - Announcements - Camli... - Camlin Fine Sciences Ltd share...
-
04-Aug-2026( 04:37)
Corporate News - Camli... - Camlin Fine Sciences Limited w...
-
01-Jun-2026( 01:01)
Corporate News - Camli... - Camlin Fine Sciences announced...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 837.92 | 886.49 | 773.26 | 789.44 | 685.51 | 600.05 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 837.92 | 886.49 | 773.26 | 789.44 | 685.51 | 600.05 |
| Other Income | 35.03 | 20.62 | 18.88 | 28.83 | 18.70 | 5.47 |
| Stock Adjustments | -40.40 | 74.91 | -8.92 | 42.61 | -4.72 | 21.83 |
| Total Income | 832.55 | 982.02 | 783.22 | 860.88 | 699.49 | 627.35 |
| EXPENDITURE : | ||||||
| Raw Materials | 405.51 | 556.18 | 434.75 | 408.30 | 389.79 | 400.22 |
| Power and Fuel Cost | 100.68 | 102.43 | 91.93 | 94.51 | 55.11 | 28.07 |
| Employee Cost | 75.98 | 72.48 | 66.28 | 60.19 | 53.32 | 38.87 |
| Other Manufacturing Expenses | 87.98 | 82.11 | 77.96 | 63.50 | 41.55 | 35.04 |
| Selling and Administration Expenses | 58.19 | 58.22 | 49.95 | 55.03 | 50.21 | 36.59 |
| Miscellaneous Expenses | 29.44 | 106.39 | 11.09 | 17.99 | 10.80 | 18.06 |
| Employee Benefit Expenses | 75.98 | 72.48 | 66.28 | 60.19 | 53.32 | 38.87 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.34 | 0.47 | 0.43 | 0.17 |
| Total Expenses | 757.78 | 977.81 | 731.62 | 699.05 | 600.35 | 556.68 |
| Operating Profit | 74.76 | 4.22 | 51.61 | 161.84 | 99.15 | 70.66 |
| Interest | 75.18 | 75.12 | 61.85 | 62.39 | 36.39 | 36.36 |
| Gross Profit | -0.42 | -70.90 | -10.24 | 99.45 | 62.76 | 34.30 |
| Depreciation | 53.68 | 52.53 | 49.39 | 32.82 | 26.68 | 19.28 |
| Profit Before Tax | -54.10 | -123.43 | -59.63 | 66.63 | 36.08 | 15.02 |
| Current Tax | 0.00 | 1.66 | 0.00 | 13.92 | 6.40 | 2.78 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -21.13 | -48.78 | -8.24 | 5.15 | 3.81 | 3.96 |
| Reported Net Profit | -32.97 | -76.31 | -51.39 | 47.55 | 25.87 | 8.28 |
| Extraordinary Items | -17.54 | -94.73 | -2.33 | -0.18 | 0.00 | -0.26 |
| Adjusted Net Profit | -15.43 | 18.42 | -49.06 | 47.73 | 25.87 | 8.54 |
| Adjustment below Net Profit | -0.10 | -0.08 | 0.00 | -0.57 | -0.43 | -0.76 |
| P & L Balance brought forward | 49.03 | 125.40 | 176.79 | 129.81 | 104.36 | 96.84 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | -0.13 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 16.09 | 49.03 | 125.40 | 176.79 | 129.81 | 104.36 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -1.72 | -4.06 | -3.07 | 3.03 | 1.65 | 0.65 |
| Earnings Per Share(Adj)-Unit Curr | -1.72 | -4.06 | -3.00 | 2.96 | 1.61 | 0.63 |
| Book Value | 48.18 | 45.71 | 42.54 | 40.67 | 37.52 | 32.59 |
| Book Value(Adj)-Unit Curr | 48.18 | 45.71 | 41.56 | 39.73 | 36.65 | 31.84 |
